Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.
Primary Objectives:
The study objective is to increase the number of participants on prostate cancer clinical trials at LBJ. Investigators will complete several objectives:
Inclusion Criteria:
These criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who
Are eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period
Can provide informed consent.
Exclusion Criteria:
These criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.
dpain@mdanderson.org(713) 745-0075